Clinical Trial Update: Adjuvant Therapy With Pergolide in Treating Cognitive Deficits in Schizophrenia [NA]

View source ↗

Summary

A completed clinical trial assessing pergolide as adjuvant therapy for cognitive deficits in schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Pergolide (pergolide)

Snippet

Sponsor: Heidelberg University | Conditions: Schizophrenia | NA | Status: COMPLETED